Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.

Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.

Item

http://www.wikidata.org/entity/Q44130699

Q44130699

about

Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.

Item

http://www.wikidata.org/entity/Q44130699

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@en

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@nl

type

Item

label

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@en

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@nl

prefLabel

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@en

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@nl

P1476

Comparison of antiplatelet eff ...... on-inferiority clinical trial.

@en

P2093

Bon-Kwon Koo

http://www.w3.org/2001/XMLSchema#string

Dong-Ju Choi

http://www.w3.org/2001/XMLSchema#string

Hae-Young Lee

http://www.w3.org/2001/XMLSchema#string

Hyo-Soo Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jae Kang

http://www.w3.org/2001/XMLSchema#string

Kyung-Woo Park

http://www.w3.org/2001/XMLSchema#string

Myung-A Kim

http://www.w3.org/2001/XMLSchema#string

Sahmin Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.

Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.

Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.

Impact of platelet function test on platelet responsiveness and clinical outcome after coronary stent implantation: platelet responsiveness and clinical outcome.

P2888

s40256-013-0039-y

P304

413-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-013-0039-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Byung-Hee Oh

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23913405

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

phase IV clinical trial

Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.

about

Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921